Financial statements Cytopath

Balance sheet of Cytopath

Company age:
Age:
10 y. 9 m. 28 d.
Share capital:
Share capital:
600 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of CYTOPATH

Year
2018
2019
2020
2021
2022
2023
Total assets 1 220 892,11 548 170,81 500 342,54 502 086,76 444 394,26 935 874,22
A. Fixed assets 764 485,96 216 784,80 147 682,26 64 219,04 0,00 106 357,79
B. Current assets 456 406,15 331 386,01 352 660,28 437 867,72 444 394,26 829 516,43
C. Share capital contributions (basic funds) 0,00 - - - - -
D. Own shares (stocks) 0,00 - - - - -
Total liabilities 1 220 892,11 548 170,81 500 342,54 502 086,76 444 394,26 935 874,22
A. Equity -1 640 933,91 -2 243 078,67 -2 380 777,82 -1 851 022,31 -1 837 650,99 -484 397,25
B. Liabilities and provisions for liabilities 2 861 826,02 2 791 249,48 2 881 120,36 2 353 109,07 2 282 045,25 1 420 271,47
I. Long-term liabilities 1 100 652,14 977 072,37 38 211,44 19 687,50 0,00 179 332,61
II. Short-term liabilities 1 678 889,56 1 687 371,08 2 757 075,08 2 239 899,93 2 181 556,60 1 240 938,86
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.